Results 251 to 260 of about 85,787 (336)
Pharmaco-genomic characterization of pancreatic and biliary tract cancer tumoroids for drug response. [PDF]
Fang K +11 more
europepmc +1 more source
Role of Salt and Water in the Plasticization of PDAC/PSS Polyelectrolyte Assemblies.
Ran Zhang +4 more
semanticscholar +1 more source
ABSTRACT Background Pancreatectomy for pancreatic ductal adenocarcinoma (PDAC) with arterial abutment is a complex, high‐risk surgery. We aimed to investigate the clinicopathological features, risk factors, and learning curve for local recurrence after pancreatectomy for PDAC with arterial abutment.
Jun Ishida +9 more
wiley +1 more source
PanMETAI - a high performance tabular foundation model for accurate pancreatic cancer diagnosis via NMR metabolomics. [PDF]
Wu DN +14 more
europepmc +1 more source
ABSTRACT Background The annual number of pancreatoduodenectomies (PDs) in the United States has increased over the past decade, but the facility types driving this growth and whether outcomes have improved remain unclear. We aimed to identify characteristics of facilities with increasing PD volumes and assess national trends in centralization ...
Koichi Tomita, Naruhiko Ikoma
wiley +1 more source
Dysregulated expression of cell cycle regulators CDC20, PLK1, BUB1, CDC45, CDCA5 in pancreatic ductal adenocarcinoma. [PDF]
Naeem M +6 more
europepmc +1 more source
This narrative review provides a comprehensive overview of liquid biopsy biomarkers for early detection of gastrointestinal cancers focusing on technological innovations, clinical performance and ongoing clinical trials. Abstract Early detection of gastrointestinal (GI) cancers remains a critical unmet clinical need, as most patients are diagnosed at ...
Muhammad Anees +11 more
wiley +1 more source
Prediagnosis diabetes, life-course body mass index and physical activity, and pancreatic cancer survival in older adults. [PDF]
Peeri NC +4 more
europepmc +1 more source
Tumour‐targeted fluorescence‐guided surgery (Ttfgs) enhances intraoperative precision in gastrointestinal cancer treatment. Translation of (Ttfgs) into clinical practice is limited by heterogeneity, regulatory hurdles, biomarker variability and absence of phase III trials.
Aaya Darai +7 more
wiley +1 more source

